BEAM
$23.47-5.10%
Beam Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.005%Russell 3000 0.004%
Beam Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Beam Therapeutics Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $27.72 | $23.47 | 0.0% | -15.3% | |
| 2025 | $24.80 | $27.72 | 0.0% | +11.8% | |
| 2024 | $27.22 | $24.80 | 0.0% | -8.9% | |
| 2023 | $39.11 | $27.22 | 0.0% | -30.4% | |
| 2022 | $79.69 | $39.11 | 0.0% | -50.9% | |
| 2021 | $81.64 | $79.69 | 0.0% | -2.4% |
- Annualized
- +0.6%
- 2021–2026
- Average year
- -16.2%
- 5 full years
- Best year
- +11.8%
- 2025
- Worst year
- -50.9%
- 2022
- Positive years
- 1/5
- 20% up
Annualized (CAGR)
+0.6%
2021–2026
Average year
-16.2%
5 full years
Best year
+11.8%
2025
Worst year
-50.9%
2022
Positive years
1/5
20% up
Total return by period#
Annual
-40%-20%0%20%40%
2021-2.4%'21
2022-51%'22
2023-30%'23
2024-8.9%'24
2025+12%'25
2026-15%'26
Methodology#
Total returns, dividends reinvested, measured on BEAM. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Beam Therapeutics Inc.'s average annual return?
- Since 2021, Beam Therapeutics Inc. (BEAM) has returned about 0.6% a year (the compound annual growth rate) and an average calendar-year return of -16.2%.
- What were Beam Therapeutics Inc.'s best and worst years?
- Over 2021–2026, the best year was 2025 (+11.8%) and the worst was 2022 (-50.9%).
- How often is Beam Therapeutics Inc. up in a year?
- 1 of the 5 full years since 2021 were positive — about 20% of the time.
More on Beam Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100